COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
| Autor: | Pier Paolo Bassareo, Paola Neroni, Jawahar L. Mehta, Vassilios Fanos, Cesare de Gregorio, Gianfranco Butera, Giuseppe Calcaterra |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
Pediatrics medicine.medical_specialty Opinion Myocarditis Coronavirus disease 2019 (COVID-19) Kawasaki-like syndrome Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pericarditis Multi-system inflammatory disease SARS-CoV-2 multi-system inflammatory disease Disease pericarditis RJ1-570 Vaccine administration vaccine medicine Critically ill business.industry medicine.disease Medicine myocarditis business |
| Zdroj: | Pediatric Reports, Vol 13, Iss 61, Pp 530-533 (2021) Pediatric Reports |
| ISSN: | 2036-7503 |
| Popis: | The alarming onset of some cases of myocarditis and pericarditis following the administration of Pfizer–BioNTech and Moderna COVID-19 mRNA-based vaccines in adolescent males has recently been highlighted. All occurred after the second dose of the vaccine. Fortunately, none of patients were critically ill and each was discharged home. Owing to the possible link between these cases and vaccine administration, the US and European health regulators decided to continue to investigate the potential causal relationship between COVID-19 mRNA vaccines and myocarditis. In any case, none of the patients fulfilled the criteria for multi-system inflammatory syndrome or Kawasaki-like disease and there was no evidence of acute SARS-CoV-2 infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|